Tekmira Pharmaceuticals will supply one of its experimental Ebola treatments for clinical studies to be conducted in West Africa.» Read More
Companies making headlines before the bell Monday.
Weaker growth overseas will keep interest rates and commodity prices low, creating tailwinds for U.S. businesses, strategist Bob Doll tells CNBC.
Russia's MICEX Index looks cheap compared to Apple, Paul Gambles, managing partner at MBMG Group, told CNBC.
It’s his annual appeal. "Mad Money" host Jim Cramer wants you to place a couple shares of this stock in the stockings.
No news is good news! Cramer shares the unspoken rules of the market as we approach year end, and what he's got his eye on.
The "Fast Money" traders give their final trades of the day.
Enrolling people in savings plans with the ability to opt out has proven to help people save. But not everyone likes the idea of auto IRAs.
Meredith Whitney's hedge fund Kenbelle Capital may be in trouble only a year after it launched.
Jim Cramer spoke with Red Hat CEO on how widespread the attack on Sony could be. Is this open sourced technology biz vulnerable to attack?
Noted investor Dennis Gartman told CNBC he's like to think oil is stabilizing, with the vast majority of the move over.
CEO Hans Bishop told CNBC investors are feeling optimistic about immunotherapy and the company's cancer treatments in development.
Howard Marks thinks that the drop in oil prices could finally expose low lending standards and provide better value in the markets.
Low interest rates and inflation and sound corporate management will yield great stock market returns, said RBC's chief market strategist.
A sudden rally shocks the Street. Making sense of the market, with CNBC's Melissa Lee and the Options Action traders, Mike Khouw, Dan Nathan & Carter Worth.
The traders shun growth stocks, as high-flyers sink. Is it time to get out of Netflix? With CNBC's Melissa Lee and the Options Action traders.
Some of Friday midday movers:
One trader got in on the Golden Arches, in the single biggest options trade of the day.
Last-minute retail shoppers outspend the rest of us at Christmas, but that can't save our stocks.
Your stock portfolio isn't on track to beat the S&P 500 this year? Well done, says financial advisor Mitch Goldberg.
The IPO business: This year was huge for IPOs, and 2015 may be even better.
Get the best of CNBC in your inbox